MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1664-5553|6|2|113-125

ISSN： 2235-1795

Source： Liver Cancer, Vol.6, Iss.2, 2016-12, pp. : 113-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 33, Iss. 6, 2015-0 ,pp. : 771-779

Karger

Access to resources Recommend Favorite

Long-Term Maintenance of Complete Response after Sorafenib Treatment for Multiple Lung Metastases from Hepatocellular Carcinoma

By  

Case Reports in Gastroenterology, Vol. 9, Iss. 2, 2015-08 ,pp. : 285-290

Karger

Access to resources Recommend Favorite

Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma

By Sinakos Emmanouil   Dedes Ioannis   Papalavrentios Lavrentis   Drevelegas Antonios   Akriviadis Evangelos  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 4, 2010-04 ,pp. : 511-512

Informa Healthcare

Access to resources Recommend Favorite

MicroRNAs and Esophageal Squamous Cell Carcinoma

By  

Digestion, Vol. 82, Iss. 3, 2010-06 ,pp. : 138-144

Karger

Access to resources Recommend Favorite

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment

By  

Liver Cancer, Vol. 4, Iss. 4, 2015-0 ,pp. : 228-240

Karger

Access to resources Recommend Favorite